InvestorsHub Logo
Followers 24
Posts 4969
Boards Moderated 0
Alias Born 07/18/2006

Re: bas2020 post# 229251

Wednesday, 01/08/2020 11:54:40 AM

Wednesday, January 08, 2020 11:54:40 AM

Post# of 466942
Forty years of scientific research on Sigma 1 antagonism has produced nothing of meaningful clinical value in humans, regardless of any preclinical data. Nothing Anavex is doing will change that. The investors who understand science best know this. AVXL is a nice trading vehicle for now but SR-1 antagonism will fall short, as it always has.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News